January 1, 2026Biomaterials Science3 citations

Targeting inflammation in hepatocellular carcinoma: emerging nanotherapeutic strategies for remodeling immunosuppressive microenvironments

HDhongyan DongZhejiang Chinese Medical University M#Meiyu Shao #Zhejiang Chinese Medical University ZTZhen TaoZhejiang Chinese Medical University

Key Points

Key points are not available for this paper at this time.

Abstract

behavior of nanocarriers, and proposed strategic directions for next-generation inflammation-targeted nanotherapeutic design, providing new perspectives for breaking the cycle of immune tolerance in HCC.

问 AI

Bookmark

View Full Paper

Cite This Study

Dong et al. (Thu,) studied this question.

synapsesocial.com/papers/6a72884f2163a0a01bc62951 https://doi.org/https://doi.org/10.1039/d5bm01798j

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Arsenic trioxide-based nanoparticles for enhanced chemotherapy by activating pyroptosis2025 · 44 citations
2TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective2022 · 149 citations
3Myeloid‑derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma2022 · 32 citations
4Tumor-Derived CCL16 Normalizes Tumor Vasculature through Macrophage ICAM-1 Receptor and Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma2025 · 7 citations
5Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy2023 · 32 citations

问 AI

Bookmark

View Full Paper